Risks associated with statin therapy: a systematic overview of randomized clinical trials.
about
Genetic determinants of statin intoleranceStatins versus placebo for people with chronic obstructive pulmonary disease (COPD)Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsisStatins for the primary prevention of cardiovascular diseaseStatins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitisStatins for aortic valve stenosisStatins for non-alcoholic steatohepatitisStatins for the primary prevention of cardiovascular diseaseStatins for the primary prevention of cardiovascular diseaseStatin adverse effects : a review of the literature and evidence for a mitochondrial mechanismStatins and its hepatic effects: Newer data, implications, and changing recommendationsBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesA point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive CardiologyTreatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patientsPhenotype standardization for statin-induced myotoxicityNon-cardiovascular effects associated with statinsStatin Therapy: Review of Safety and Potential Side EffectsStatin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementRhabdomyolysis: pathogenesis, diagnosis, and treatmentUse of imaging and clinical data to screen for cardiovascular disease in asymptomatic diabetics.Treatment strategies in patients with statin intolerance: the Cleveland Clinic experience.Myopathy in Patients Taking Atorvastatin: A Pilot Study.Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch databaseSafety of statins: an updateStatin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients.What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.Efficacy of short-term high-dose statin pretreatment in prevention of contrast-induced acute kidney injury: updated study-level meta-analysis of 13 randomized controlled trialsEffects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study.Mechanisms and assessment of statin-related muscular adverse effects.Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathwaysDiscontinuation of statins in routine care settings: a cohort study.Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".Impact of the New ACC/AHA Guidelines on the Treatment of High Blood Cholesterol in a Managed Care Setting.Reasons for discontinuation of lipid-lowering medications in patients with chronic kidney disease.Comparative Effectiveness and Toxicity of Statins Among HIV-Infected PatientsPreventive medication use among persons with limited life expectancy.Clinician's guide to the updated ABCs of cardiovascular disease prevention.Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence.Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) DatabaseDo cinnamon supplements cause acute hepatitis?
P2860
Q21245682-75137BAD-E84A-4FC0-AC89-A0226AF76423Q24188188-9481395D-7FB6-48E0-B3BF-EB1173ED5E70Q24193361-5B0F4962-5E2E-49B7-929B-928C1153F814Q24201513-6D88CFB8-3A72-452A-B170-87CDB3CEDB67Q24201595-49D2B9FD-AF5F-4E2F-B470-E5015BFDC63DQ24203993-178AC33F-6DD0-4463-B7E1-34E9B067D53EQ24234628-AFC4293E-F323-458D-B4D6-9849E5074519Q24234813-9B20A86F-8AC9-4564-A06E-302CEA4686C0Q24240283-FFA95702-DD06-4B63-81BD-14FC1985F826Q24603957-98D3A762-B8A6-4FDD-ADE8-6C0EC7C54098Q26767065-6294C81D-F2BC-4DB5-A7C8-24190C68E4AEQ26853571-D6D3B13A-741A-4285-8E88-094E5F946760Q26866033-826FBCCC-F069-4D37-BECD-D59774E079BAQ26996051-D9439E18-39BC-4F3B-8063-7C76D4907284Q27020935-C9A9D419-871C-4245-9049-0000B4C41603Q27026332-5CD46223-137C-4E1E-A1CD-66F85BC4C8F6Q28072883-5A8916F5-5F04-47DE-A452-B0223697F07FQ28083004-364A9FF0-6413-40BB-82E6-9B970E7E05F2Q28087634-76655375-D1EA-4AFB-B124-4FEEF63FD6E7Q31043922-69696762-F232-4D84-A0A4-3E999EF7C1D2Q33684643-AFE09D8A-8A0D-46F6-ABFC-1151174A9490Q33815469-767E8AE9-BA84-497B-A355-94E1CE545100Q33867311-EC947EB1-8604-4DF8-8099-447AC1BFAC7AQ33949312-E72C1F48-FE0A-4134-9F50-86AE4DFB8D27Q34169932-BE38FE4A-28B6-4E62-997D-8EFDE8AF874FQ34409791-5CEE4D13-7612-4978-9BE9-56819E0AD3F0Q34450309-0ACD825B-483C-4507-A4A8-4C0744FDED57Q34451383-96FDC729-F21D-4718-BA4B-A64AF1A4F8B4Q34570995-CFFA856B-BA0A-459B-BDB8-3B1259C9F66EQ34578989-643C12EB-4577-4EB0-BDDD-E3D8BC8971BAQ34644409-F0DAE8F0-CF8E-4CD1-BFE9-B3487C576AB9Q34654243-70A1B894-1AB6-4B24-AC61-A7D773ED3309Q34792459-9033CE68-3594-4917-867C-0B70856904DCQ34985796-94D044F0-0B61-453D-A28A-01B58BCD6C7FQ35019859-37A50FA3-E384-49DE-9D68-0862F83CAF02Q35055271-439BE284-2E11-411E-ACE4-04F9C74C25F7Q35070830-A1E54857-D1F3-48D9-92B1-B44691F5BF28Q35214678-417D73DC-CD21-4047-98A8-80BB56814B91Q35282895-924DCEB0-7305-423D-AA73-6A0155AE372AQ35579259-FD04E4C9-4C50-4698-A4D2-ED6C7F350E1D
P2860
Risks associated with statin therapy: a systematic overview of randomized clinical trials.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Risks associated with statin t ...... of randomized clinical trials.
@ast
Risks associated with statin t ...... of randomized clinical trials.
@en
Risks associated with statin t ...... of randomized clinical trials.
@nl
type
label
Risks associated with statin t ...... of randomized clinical trials.
@ast
Risks associated with statin t ...... of randomized clinical trials.
@en
Risks associated with statin t ...... of randomized clinical trials.
@nl
prefLabel
Risks associated with statin t ...... of randomized clinical trials.
@ast
Risks associated with statin t ...... of randomized clinical trials.
@en
Risks associated with statin t ...... of randomized clinical trials.
@nl
P2093
P1433
P1476
Risks associated with statin t ...... of randomized clinical trials.
@en
P2093
Amir Kashani
Christopher O Phillips
JoAnne M Foody
Sandeep Mangalmurti
Yongfei Wang
P304
P356
10.1161/CIRCULATIONAHA.106.624890
P407
P577
2006-12-11T00:00:00Z